Search Results 51-60 of 16141 for Liposarcoma

  1. Ewing Sarcoma Clinical Trials

    ... liposarcoma, osteosarcoma. Since we do not know if any of these types of drugs help people with liposarcoma, osteosarcoma, or Ewing/Ewing-like sarcoma, our ...

  2. Mayo Clinic Comprehensive Cancer Center — Research

    ... liposarcoma that progressed on 1 or more prior systemic therapies, including at least 1 anthracycline-based therapy. High Risk Human Papilloma Virus (hrHPV) ...

  3. centers-of-excellence

    Treatment of Milademetan Versus Trabectedin in Patient With Dedifferentiated Liposarcoma (MANTRA) - Mayo Clinic. Overview Tab ...

  4. Mayo Clinic Comprehensive Cancer Center — Research

    ... liposarcoma that progressed on 1 or more prior systemic therapies, including at least 1 anthracycline-based therapy. High Risk Human Papilloma Virus (hrHPV) ...

  5. Angiosarcoma - Doctors and departments - Mayo Clinic

    astasis, Liposarcoma, Ewing sarcoma, Chondrosarcoma, Angiosarcoma, Rhabdomyosarcoma, Epithelioid sarcoma, Sarcoma, Malignant peripheral nerve sheath tumors ...

  6. Mayo Clinic Comprehensive Cancer Center — Research

    The purpose of this study is to evaluate abemaciclib versus placebo to treat Advanced Dedifferentiated Liposarcoma. Patients with progression of disease ...

  7. Synovial Sarcoma Clinical Trials

    ... Liposarcoma Jacksonville, FL. The purpose of this study is to evaluate ... Liposarcoma (MRCLS) who have received prior chemotherapy and whose tumor ...

  8. MDM2 Inhibitor AMG-232 and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma - Mayo Clinic

    Well- differentiated liposarcoma or other low grade STS; Kaposi sarcoma, bone sarcomas, cartilage sarcomas and GIST. Definitive clinical or radiologic ...

  9. Mayo Clinic Comprehensive Cancer Center — Research

    ... liposarcoma that progressed on 1 or more prior systemic therapies, including at least 1 anthracycline-based therapy. High Risk Human Papilloma Virus (hrHPV) ...

  10. Publications - Peter S. Rose, M.D. - Mayo Clinic

    Lack of radiosensitivity predicts poor disease specific survival in myxoid liposarcoma. J Surg Oncol. 2023 Apr; 127 (5):848-854 Epub 2022 Dec 27. View PubMed ...